Related Experiment Video
Updated: Jun 14, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
Acalculous candidal cholecystitis after pediatric renal transplant
Jennifer Grosser1, Harvey Solomon, Cirilo Sotelo-Avila
1Department of Surgery, Saint Louis University Hospital, St. Louis, MO 63110, USA. jgrosser@slu.edu
Abstract:
AAC caused by Candida is an uncommon entity usually seen in the critically ill. Here, we present the case of an 18-month-old renal transplant patient who developed candidal AAC during the post-operative period. Previous articles have addressed acalculous cholecystitis secondary to a variety of causes, or addressed a wide variety of Candida infections in the biliary tract, but this is the first discussion of cholecystitis caused by Candida without confounding factors such as biliary calculi or multiple pathogens. After the discussion of our patient's case, we also reviewed the English-language literature regarding candidal AAC and discussed diagnosis, treatment, and mortality.
Insights
This study details a rare case of acalculous cholecystitis caused by Candida in a pediatric renal transplant patient. It highlights the importance of considering fungal infections in post-operative biliary complications.
Area of Science:
- Medical Mycology
- Transplant Surgery
- Gastroenterology
Background:
- Acalculous cholecystitis (AAC) is uncommon, particularly in non-critically ill patients.
- Candida species are known pathogens but rarely cause AAC.
- Renal transplant recipients are immunocompromised, increasing susceptibility to opportunistic infections.
Observation:
- An 18-month-old renal transplant patient developed AAC post-operatively.
- The patient's AAC was attributed solely to Candida, without biliary calculi or other pathogens.
- This case represents a unique presentation of candidal AAC.
Findings:
- The study presents the first documented case of Candida-induced AAC without confounding factors.
- Literature review on candidal AAC, diagnosis, treatment, and mortality was conducted.
- Key diagnostic and therapeutic strategies for candidal AAC were discussed.
Implications:
- Highlights the need to consider Candida as a causative agent for AAC in immunocompromised patients, especially post-transplant.
- Emphasizes the importance of early diagnosis and targeted antifungal therapy.
- Contributes to understanding the clinical spectrum and management of invasive fungal infections in transplant recipients.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Cholecystitis
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction